Quadrature Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-105,744
| Closed | -$19.6M | – | 1472 |
|
|
2025
Q3 | $19.6M | Buy |
+105,744
| New | +$18.1M | 0.23% | 91 |
|
|
2025
Q2 | – | Sell |
-4,207
| Closed | -$698K | – | 1277 |
|
|
2025
Q1 | $698K | Buy |
+4,207
| New | +$658K | 0.02% | 503 |
|
|
2024
Q3 | – | Sell |
-54,721
| Closed | -$8M | – | 1175 |
|
|
2024
Q2 | $8M | Buy |
+54,721
| New | +$8.14M | 0.13% | 137 |
|
|
2024
Q1 | – | Sell |
-126,301
| Closed | -$19.8M | – | 1349 |
|
|
2023
Q4 | $19.8M | Sell |
126,301
-13,649
| -10% | -$2.09M | 0.36% | 57 |
|
|
2023
Q3 | $21.8M | Sell |
139,950
-24,432
| -15% | -$4.03M | 0.45% | 55 |
|
|
2023
Q2 | $27.2M | Buy |
+164,382
| New | +$26.5M | 0.6% | 41 |
|
|
2023
Q1 | – | Sell |
-121,720
| Closed | -$21.5M | – | 1052 |
|
|
2022
Q4 | $21.5M | Buy |
121,720
+85,951
| +240% | +$14.8M | 0.64% | 35 |
|
|
2022
Q3 | $5.85M | Sell |
35,769
-31,622
| -47% | -$5.35M | 0.19% | 128 |
|
|
2022
Q2 | $12M | Sell |
67,391
-61,075
| -48% | -$10.9M | 0.5% | 59 |
|
|
2022
Q1 | $22.8M | Buy |
128,466
+8,584
| +7% | +$1.46M | 0.92% | 25 |
|
|
2021
Q4 | $20.5M | Buy |
119,882
+4,446
| +4% | +$728K | 1.08% | 19 |
|
|
2021
Q3 | $18.6M | Buy |
115,436
+13,317
| +13% | +$2.27M | 0.68% | 39 |
|
|
2021
Q2 | $16.8M | Buy |
102,119
+79,352
| +349% | +$13.1M | 0.64% | 41 |
|
|
2021
Q1 | $3.74M | Buy |
+22,767
| New | +$3.68M | 0.18% | 117 |
|
|
2019
Q4 | – | Sell |
-334,832
| Closed | -$43.3M | – | 608 |
|
|
2019
Q3 | $43.3M | Buy |
334,832
+289,601
| +640% | +$38.2M | 2.09% | 5 |
|
|
2019
Q2 | $6.29M | Sell |
45,231
-72,049
| -61% | -$9.97M | 0.42% | 76 |
|
|
2019
Q1 | $16.4M | Buy |
+117,280
| New | +$15.7M | 1.4% | 12 |
|
|
2018
Q4 | – | Sell |
-19,675
| Closed | -$2.72M | – | 574 |
|
|
2018
Q3 | $2.72M | Buy |
+19,675
| New | +$2.61M | 0.23% | 109 |
|
|
2016
Q3 | – | Sell |
-37,354
| Closed | -$4.53M | – | 650 |
|
|
2016
Q2 | $4.53M | Buy |
37,354
+17,125
| +85% | +$1.95M | 0.34% | 78 |
|
|
2016
Q1 | $2.19M | Sell |
20,229
-21,698
| -52% | -$2.25M | 0.3% | 96 |
|
|
2015
Q4 | $4.31M | Buy |
+41,927
| New | +$4.22M | 0.66% | 29 |
|
|
2015
Q3 | – | Sell |
-5,209
| Closed | -$507K | – | 296 |
|
|
2015
Q2 | $507K | Buy |
+5,209
| New | +$522K | 0.46% | 69 |
|
|
2015
Q1 | – | Sell |
-2,000
| Closed | -$209K | – | 123 |
|
|
2014
Q4 | $209K | Buy |
+2,000
| New | +$211K | 0.77% | 70 |
|
Other funds holding JNJ
Quadrature Capital's JNJ Position: Q4 2025 in Review
Quadrature Capital sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 105,744 shares — an estimated $19.6M sold.
Quadrature Capital first reported a position in JNJ in Q4 2014 and held it in 23 quarters. The position peaked at $43.3M in Q3 2019. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.
- Quadrature Capital reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
- Quadrature Capital sold 105,744 Johnson & Johnson shares in Q4 2025, an estimated $19.6M.
- Quadrature Capital first reported a position in Johnson & Johnson in Q4 2014 and held it in 23 quarters.
- Quadrature Capital's Johnson & Johnson position peaked at $43.3M in Q3 2019.
- 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.
Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.